Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Charles D Smith

Showing results (151-160 of 200) with videos related to

Pageof 20
Sort By:
Computer Methods and Programs in Biomedicine|March 7, 2014
Spectral and complexity analysis of scalp EEG characteristics for mild cognitive impairment and early Alzheimer's diseaseJoseph C McBride, Xiaopeng Zhao, Nancy B Munro, et al.
Molecular Cancer Therapeutics|October 24, 2015
The Sphingosine Kinase 2 Inhibitor ABC294640 Reduces the Growth of Prostate Cancer Cells and Results in Accumulation of Dihydroceramides In Vitro and In VivoHeather Venant, Mehrdad Rahmaniyan, E Ellen Jones, et al.
Brain and Behavior|March 1, 2016
Peripheral (deep) but not periventricular MRI white matter hyperintensities are increased in clinical vascular dementia compared to Alzheimer's diseaseCharles D Smith, Eleanor S Johnson, Linda J Van Eldik, et al.
Brain Sciences|July 24, 2019
White Matter Hyperintensity Regression: Comparison of Brain Atrophy and Cognitive Profiles with Progression and Stable GroupsOmar M Al-Janabi, Christopher E Bauer, Larry B Goldstein, et al.
AIMS Neuroscience|July 2, 2020
Brain structure changes over time in normal and mildly impaired aged personsCharles D Smith, Linda J Van Eldik, Gregory A Jicha, et al.
Dementia and Geriatric Cognitive Disorders|January 24, 2015
Assessing the discriminant ability, reliability, and comparability of multiple short forms of the Boston Naming Test in an Alzheimer's disease center cohortYuriko Katsumata, Melissa Mathews, Erin L Abner, et al.
Inflammopharmacology|October 12, 2010
Attenuation of arthritis in rodents by a novel orally-available inhibitor of sphingosine kinaseLeo R Fitzpatrick, Cecelia Green, Elizabeth E Frauenhoffer, et al.
Journal of Neuropathology and Experimental Neurology|February 7, 2007
TDP-43 in the ubiquitin pathology of frontotemporal dementia with VCP gene mutationsManuela Neumann, Ian R Mackenzie, Nigel J Cairns, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|May 31, 2016
A clinical trial to validate event-related potential markers of Alzheimer's disease in outpatient settingsMarco Cecchi, Dennis K Moore, Carl H Sadowsky, et al.
Science Signaling|June 18, 2015
Binding of the sphingolipid S1P to hTERT stabilizes telomerase at the nuclear periphery by allosterically mimicking protein phosphorylationShanmugam Panneer Selvam, Ryan M De Palma, Joshua J Oaks, et al.
Pageof 20

Showing results (151-160 of 200) with videos related to

Sort By:
Pageof 20
Computer Methods and Programs in Biomedicine|March 7, 2014
Spectral and complexity analysis of scalp EEG characteristics for mild cognitive impairment and early Alzheimer's diseaseJoseph C McBride, Xiaopeng Zhao, Nancy B Munro, et al.
Molecular Cancer Therapeutics|October 24, 2015
The Sphingosine Kinase 2 Inhibitor ABC294640 Reduces the Growth of Prostate Cancer Cells and Results in Accumulation of Dihydroceramides In Vitro and In VivoHeather Venant, Mehrdad Rahmaniyan, E Ellen Jones, et al.
Brain and Behavior|March 1, 2016
Peripheral (deep) but not periventricular MRI white matter hyperintensities are increased in clinical vascular dementia compared to Alzheimer's diseaseCharles D Smith, Eleanor S Johnson, Linda J Van Eldik, et al.
Brain Sciences|July 24, 2019
White Matter Hyperintensity Regression: Comparison of Brain Atrophy and Cognitive Profiles with Progression and Stable GroupsOmar M Al-Janabi, Christopher E Bauer, Larry B Goldstein, et al.
AIMS Neuroscience|July 2, 2020
Brain structure changes over time in normal and mildly impaired aged personsCharles D Smith, Linda J Van Eldik, Gregory A Jicha, et al.
Dementia and Geriatric Cognitive Disorders|January 24, 2015
Assessing the discriminant ability, reliability, and comparability of multiple short forms of the Boston Naming Test in an Alzheimer's disease center cohortYuriko Katsumata, Melissa Mathews, Erin L Abner, et al.
Inflammopharmacology|October 12, 2010
Attenuation of arthritis in rodents by a novel orally-available inhibitor of sphingosine kinaseLeo R Fitzpatrick, Cecelia Green, Elizabeth E Frauenhoffer, et al.
Journal of Neuropathology and Experimental Neurology|February 7, 2007
TDP-43 in the ubiquitin pathology of frontotemporal dementia with VCP gene mutationsManuela Neumann, Ian R Mackenzie, Nigel J Cairns, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|May 31, 2016
A clinical trial to validate event-related potential markers of Alzheimer's disease in outpatient settingsMarco Cecchi, Dennis K Moore, Carl H Sadowsky, et al.
Science Signaling|June 18, 2015
Binding of the sphingolipid S1P to hTERT stabilizes telomerase at the nuclear periphery by allosterically mimicking protein phosphorylationShanmugam Panneer Selvam, Ryan M De Palma, Joshua J Oaks, et al.
Pageof 20